Q&A: Fran­co Ste­van­to leads fam­i­ly busi­ness through pan­dem­ic, IPO and on­to the glob­al stage

As the US gov­ern­ment con­tin­ues to dump mon­ey in­to vial and pack­ag­ing man­u­fac­tur­ing, Ital­ian vial man­u­fac­tur­er Ste­vana­to Group has tak­en full ad­van­tage.

It broke ground in Oc­to­ber on a $145 mil­lion man­u­fac­tur­ing site in Fish­ers, IN to bring its op­er­a­tions clos­er to US cus­tomers, build­ing a 370,000 square-foot site that will re­duce the time it takes for drugs to get to mar­ket. Then at the start of the month, the group an­nounced that it will get $95 mil­lion from the De­part­ment of De­fense to ex­pand its stan­dard and EZ-Fill vial ca­pac­i­ty to pre­pare for fu­ture pan­dem­ic pre­pared­ness.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER